Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 5.27
+0.14 (2.73%)
Mar 6, 2026, 4:08 PM HKT
17.63% (1Y)
| Market Cap | 17.34B +17.6% |
| Revenue (ttm) | 5.88B -1.0% |
| Net Income | 459.25M |
| EPS | 0.31 |
| Shares Out | n/a |
| PE Ratio | 37.76 |
| Forward PE | n/a |
| Dividend | 0.27 (5.21%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 535,500 |
| Average Volume | 778,075 |
| Open | 5.14 |
| Previous Close | 5.13 |
| Day's Range | 5.13 - 5.30 |
| 52-Week Range | 3.93 - 7.26 |
| Beta | 0.45 |
| RSI | 47.60 |
| Earnings Date | Mar 31, 2026 |